Today's News | Note: News feeds may no longer be available for the articles on this page.

Novo diabetes drug tops older medicine at two years 10:29 AM 6/7/2009
Reuters - USA
Novo Nordisk's experimental diabetes drug liraglutide was significantly better controlling blood sugar than an older common medicine after two years. ...

Glaxo's GLP-1 diabetes drug beats Byetta in test 8:39 AM 6/7/2009
Reuters - USA
Glaxo's injectable Syncria is in the class of medicines called GLP-1s like Byetta and Novo Nordisk's Victoza. It appears more effective than Eli Lilly and Amylin Pharmaceuticals' Byetta in controlling blood sugar. ...

Antipsychotic drugs appear to work in kids-FDA staff 12:17 PM 6/5/2009
Reuters - USA
Antipsychotic drugs made by AstraZeneca, Pfizer, and Eli Lilly appear to work in children and teens. Their risks must be weighed for younger patients. ...

Merck Won't Seek Approval for Heart-Failure Drug This Year 8:10 AM 6/5/2009
Wall Street Journal - USA
Merck & Co's heart failure treatment rolofylline missed its primary and secondary goals in the late-stage trial. ...

US FDA releases list of potential drug risks 4:56 PM 6/4/2009
Reuters - USA
The US FDA listed two dozen drugs including weight-loss and sleep disorder pills it is reviewing for potential safety problems. ...

PPD shares fall on diabetes drug setback 12:28 PM 6/4/2009
Forbes - NY,USA
PPD Inc's partner Takeda Pharmaceutical is postponing a submission with European regulators as it conducts an additional two-year study on the drug candidate alogliptin. ...

J&J To File 3 New Drug Applications By End Of 2010 8:41 AM 6/4/2009
Wall Street Journal - USA
Johnson & Johnson will seek approval for HIV and hepatitis C drugs by next year. J&J plans to seek US approvals for eight drugs between 2011 and 2013 for diabetes, tuberculosis, attention deficit disorder, pain, and obesity. ...

ViroPharma gets complete response letter on HAE drug 7:02 AM 6/4/2009
Reuters - USA
ViroPharma Inc said the that the US FDA declined to approve an additional indication for its treatment for a rare genetic disease wanting the company to conduct an additional clinical study. ...

AstraZeneca, Abbott Submitted New Drug Application To The FDA 7:00 AM 6/4/2009
Wall Street Journal - USA
AstraZeneca and Abbott Laboratories filed for US regulatory approval of Certriad which combines AstraZeneca's existing blockbuster statin Crestor with TriLipix that Abbott developed with Solvay. ...

Takeda to delay European application for key drug 4:59 AM 6/4/2009
Reuters - USA
Takeda Pharmaceutical will delay seeking European approval of its key diabetes drug candidate SYR-322 (alogliptin) to 2012. Alogliptin is a successor to top-selling drug Actos. ...

Experimental drug works in resistant tuberculosis 4:39 PM 6/3/2009
Reuters - USA
Johnson & Johnson drug TMC207 added to a standard cocktail of five other TB medicines cleared traces of the tuberculosis bacteria in the sputum of 48 percent of the volunteers after eight weeks. ...

FDA approves Pfizer cancer drug for dogs 3:18 PM 6/3/2009
Reuters - USA
Pfizer Inc's efforts to develop new cancer drugs yield a breakthrough for dogs. The drug Palladia was approved to treat canine mast cell tumors. ...

Questions Swirl Around Avastin 12:23 PM 6/3/2009
Forbes - NY,USA
Cancer researchers wonder why Roche's lucrative drug Avastin is not providing bigger survival gains for cancer patients. It was the biggest prize in Roche's $47 billion deal to purchase the Genentech equity it did not own. ...

Autism not helped by antidepressant drug 4:05 AM 6/3/2009
United Press International - USA
US researchers report that the antidepressant drug citalopram is no better than a placebo when treating autism behavior such as rocking and spinning. ...

Anti-clot drug combinations boost bleeding risks 3:26 PM 6/2/2009
Reuters - USA
Clot-preventing drugs such as aspirin, Coumadin (warfarin), and Plavix (clopidogrel) given to heart patients in combinations can significantly increase the risk of stomach or intestinal bleeding. ...

<- Day Earlier | Today's News